Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Rheumatic Diseases|June 9, 2025
Potentially Elevated Rheumatoid Arthritis Risk due to Chemotherapy-Induced Inflammation in Prostate Cancer With Bone MetastasisJide He, Zenan Liu, Qianyang Ni, et al.
Cellular Immunology|February 15, 2020
Dehydrocostus lactone inhibits NLRP3 inflammasome activation by blocking ASC oligomerization and prevents LPS-mediated inflammation in vivoYuanyuan Chen, Ruisheng Li, Zhilei Wang, et al.
Rheumatology (Oxford, England)|February 7, 2025
Comparison of the efficacy and safety of methotrexate injection and methotrexate tablets in active RALin Qiao, Jiankang Hu, Daming Ou, et al.
RMD Open|March 8, 2024
The development and initial validation of IgG4-related disease damage index: a consensus report from Chinese IgG4-RD ConsortiumLinyi Peng, Jingna Li, Jiaxin Zhou, et al.
JAMA Network Open|April 14, 2023
Management of Rheumatoid Arthritis With a Digital Health Application: A Multicenter, Pragmatic Randomized Clinical TrialChun Li, Jianlin Huang, Huaxiang Wu, et al.
Rheumatology and Therapy|November 22, 2021
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III StudyYanying Liu, Shengyun Liu, Lin Liu, et al.
BMC Medicine|December 8, 2025
Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trialYue Cheng, Honghu Tang, Yufeng Qing, et al.
JAMA Network Open|May 8, 2026
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical TrialJian Zhu, Cheng Zhao, Cundong Mi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 17, 2025
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled StudyShangzhu Zhang, Dong Xu, Shengyun Liu, et al.
Pageof 4